GlassScriptPhysician profile
Steven J Carr
NPI 1790988947
$11,066.50
in general payments reported to CMS, 2019-2025
37 companies · $1,785 in 2025
The $1,785 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,055 · 2020: $932 · 2021: $1,249 · 2022: $1,736 · 2023: $1,760 · 2024: $1,549 · 2025: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,094.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,832.45 | 2019-2025 | Aveir, Amplatzer Amulet, Gallant |
| Edwards Lifesciences Corporation | $1,078.08 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $1,029.11 | 2019-2024 | Xarelto |
| Amgen INC. | $745.36 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $639.22 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| E.R. Squibb & Sons, L.L.C. | $521.69 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $416.04 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.11 | 2022-2025 | Jardiance |
| Medtronic Vascular, INC. | $262.30 | 2019-2020 | |
| Pfizer INC. | $254.58 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $232.44 | 2022-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $176.45 | 2021-2024 | Dupixent |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.31 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $148.99 | 2019 | |
| Jazz Pharmaceuticals INC. | $121.23 | 2021-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $105.03 | 2024 | Arcalyst |
| Novo Nordisk INC | $103.36 | 2025 | Ozempic, Wegovy, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $98.49 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| United Therapeutics Corporation | $96.50 | 2022-2024 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $89.69 | 2022-2024 | Farxiga |
| Shockwave Medical, INC | $71.01 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $54.44 | 2022-2023 | |
| Amarin Pharma, INC. | $53.66 | 2021 | |
| Mallinckrodt Hospital Products INC. | $52.51 | 2022-2023 | Acthar |
| Stryker Corporation | $44.31 | 2019 | |
| Recor Medical INC | $39.19 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cvrx, INC. | $33.97 | 2024 | Barostim Neo System |
| Elutia, INC. | $31.89 | 2021 | |
| Boston Scientific Corporation | $23.77 | 2025 | Synergy |
| Baxter Healthcare | $21.93 | 2025 | Hillrom - Monarch Airway Clearance System |
| Abiomed | $19.59 | 2025 | |
| Inspire Medical Systems, INC. | $19.17 | 2023 | Inspire |
| Kestra Medical Technology Services, INC. | $17.76 | 2025 | Assure Wcd |
| Inari Medical, INC. | $17.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.81 | 2025 | |
| Angiodynamics, INC. | $13.59 | 2019 | |
| Venturemed Group, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.